AnaptysBio Inc buy Guggenheim
Start price
12.12.24
/
50%
€14.40
Target price
12.12.25
€34.37
Performance (%)
137.50%
Price
07.11.25
€34.00
Summary
This prediction is currently active. With a performance of 137.50% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 12.12.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 7.595% | 7.595% |
| iShares Core DAX® | -0.917% | -3.612% |
| iShares Nasdaq 100 | -3.301% | -0.193% |
| iShares Nikkei 225® | -4.194% | 3.000% |
| iShares S&P 500 | -1.866% | -0.116% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Guggenheim from $90.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat